In the realm of cardiac health, an exciting new study has cast light on the intricate details of our hearts, revealing significant differences between the left and right ventricles' fibroblasts. This research, conducted by a team of dedicated scientists from the...
For children diagnosed with complex heart conditions like hypertrophic cardiomyopathy (HCM), the diagnosis can be frightening for families and challenging for healthcare providers since the trajectory of the condition is often uncertain. As a leading cause of sudden...
An innovative cardiovascular start-up, HDAX Therapeutics, is the latest company to win $250,000 in funding following another year of the Ted Rogers Centre for Heart Research’s Entrepreneurship for Cardiovascular Health Opportunities (ECHO) program. The ECHO program...
Several members of the Ted Rogers Centre for Heart Research (TRCHR) participated in Vascular 2023, a five-day conference held in Montreal from October 25-29. The conference is a hallmark event organized by several Canadian specialist and research organizations,...
Researchers at the Ted Rogers Centre for Heart Research have developed an innovative approach to better understanding the complex signaling mechanisms underlying heart failure. A recent publication in the Proceedings of the National Academy of Sciences (PNAS) offers...
The Rogers Foundation announces a second landmark gift, building on its $130 million gift in 2014, to sustain the Ted Rogers Centre for Heart Research in perpetuity and bring the promise of precision cardiac health to patients across Canada and globally. In 2014, the...
3D models of heart failure… stiffened hearts in diabetes…. saving infant lives
After a heart attack, this peptide protects the heart from further injury
Featured Event
Heart Failure Symposium 2023
Virtual Library
Visit our YouTube channel filled with world-class heart failure educational sessions on diverse topics
XVIIIth International Symposium on Atherosclerosis
June 9, 2018 - June 12, 2018
The ISA 2018 Symposium will be focused on cutting-edge research in the areas of atherosclerosis, thrombosis and vascular biology and will feature:
4-day program attracting 1500+ international professionals, organized in collaboration with opinion-leaders in atherosclerosis research from across the globe;
5 exciting program tracks including: Dyslipidemia, Epidemiology, Pathogenesis, Prevention and Therapeutics;
100+ internationally recognized speakers, leading plenary and parallel scientific sessions in basic, clinical and public health science of atherosclerosis; Global innovation and public health awareness forums;
Pre- and post-meeting satellite symposia;
Ground-breaking abstracts and scientific posters;
Networking and collaboration hubs;
Industry-sponsored social events, receptions, symposia, and faculty events;